SAM
IONS icon

Smartleaf Asset Management’s Ionis Pharmaceuticals IONS Stock Holding History

Smartleaf Asset Management’s Portfolio IONS Stock Details IONS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$114K Hold
1,416
– – ﹤0.01% 1107
2026
Q1 		$103K Buy
1,416
+28
+2% +$2.21K ﹤0.01% 1100
2025
Q4 		$110K Buy
1,388
+1,284
+1,235% +$96.7K ﹤0.01% 1137
2025
Q3 		$6.67K Buy
+104
New +$5.08K ﹤0.01% 2272
2025
Q2 		– Sell
-131
Closed -$4.08K – 2852
2025
Q1 		$4.08K Sell
131
-197
-60% -$6.45K ﹤0.01% 2259
2024
Q4 		$11.5K Sell
328
-99
-23% -$3.7K ﹤0.01% 1940
2024
Q3 		$17.4K Buy
427
+368
+624% +$17.1K ﹤0.01% 1429
2024
Q2 		$2.79K Buy
59
+33
+127% +$1.35K ﹤0.01% 2083
2024
Q1 		$1.16K Buy
+26
New +$1.24K ﹤0.01% 1584

Other funds holding IONS

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Two Sigma Investments
Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return
Royal Bank of Canada
Royal Bank of Canada Toronto, Ontario, Canada $672B AUM 33.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return

Smartleaf Asset Management's IONS Position: Q2 2026 in Review

Smartleaf Asset Management held its Ionis Pharmaceuticals (IONS) position steady in Q2 2026 at 1,416 shares worth $114K. The position accounts for ﹤0.01% of the portfolio, ranked #1107.

Smartleaf Asset Management first reported a position in IONS in Q1 2024 and has held it in 9 quarters since. 515 funds tracked by Wall St. Rank hold IONS as of Q2 2026.

  • Smartleaf Asset Management held 1,416 shares of Ionis Pharmaceuticals worth $114K as of Q2 2026.
  • Smartleaf Asset Management left its Ionis Pharmaceuticals share count unchanged in Q2 2026.
  • Ionis Pharmaceuticals made up ﹤0.01% of Smartleaf Asset Management's portfolio in Q2 2026, its #1107 holding.
  • Smartleaf Asset Management first reported a position in Ionis Pharmaceuticals in Q1 2024 and has held it in 9 quarters since.
  • 515 funds tracked by Wall St. Rank held Ionis Pharmaceuticals as of Q2 2026.

Based on Smartleaf Asset Management's 13F filing for Q2 2026, filed 12 Aug 2026.